Tema Cardiovascular and Metabolics ETF (HRTS) Short Interest Ratio & Short Volume

Short interest is the volume of Tema Cardiovascular and Metabolics ETF shares that have been sold short but have not yet been closed out or covered. As of October 31st, traders have sold 500 shares of HRTS short. Learn More on Tema Cardiovascular and Metabolics ETF's current short interest.

Tema Cardiovascular and Metabolics ETF saw a decline in short interest in October. As of October 31st, there was short interest totaling 500 shares, a decline of 95.4% from the previous total of 10,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies compare to Tema Cardiovascular and Metabolics ETF: Siren Nasdaq NexGen Economy ETF (0.16%), Global X Genomics & Biotechnology ETF (0.18%), Tradr 2X Long Innovation ETF (6.11%), CrossingBridge Pre-Merger SPAC ETF (0.18%), iShares ESG Advanced MSCI EM ETF (0.10%), Invesco ESG NASDAQ 100 ETF (1.49%), Global X Aging Population ETF (0.06%), Global X E-Commerce ETF (0.03%), Fidelity Disruptive Communications ETF (2.31%), Fidelity Disruptors ETF (0.00%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

Short selling HRTS is an investing strategy that aims to generate trading profit from Tema Cardiovascular and Metabolics ETF as its price is falling. HRTS shares are trading up $0.39 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Tema Cardiovascular and Metabolics ETF occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of HRTS, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HRTS, twice per month. The most recent reporting period available is October, 31 2024.